Equites Radar

OCSL · Oaktree Specialty Lending Corpo

Asset ManagementUnited StatesAnalyst view: none

$11.78

+1.87% last session

End-of-day data · updated 2026-07-29

Neutral2 bullish · 2 bearish technical signals
To mean target: +5.5%

Market cap

$1B

Enterprise value

$2B

Trailing P/E

20.3

Forward P/E

8.8

Dividend yield

13.0%

Beta

0.57

Avg volume

1M

Employees

2D change

1.87%

5D change

2.74%

10D change

-1.23%

30D change

0.08%

60D change

3.23%

MTD change

-1.23%

YTD change

0.53%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts6
Mean price target$12.43
Low price target$11.50
Upside to mean target+5.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)52.6
50-day MA$11.77
200-day MA$11.80
Price vs 50-day MA+2.0%
Price vs 200-day MA+1.7%
MACD histogram-0.04
Volume vs 3-month avg0.6×
52w low $10.4052w high $12.91

Analyst sentiment over time — OCSL

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-03-13

Latest call per bank · past 12 months

JP Morgan

Neutral

$10.50

-10.9% vs price
▼ cut from $13.50Maintains · 2026-03-13

Wells Fargo

Equal-Weight

$12.00

+1.9% vs price
▼ cut from $13.00Maintains · 2026-02-05

Recent rating actions

DateFirmActionRatingPrice target
2026-03-13JP MorganMaintainsNeutral$13.50 $10.50
2026-02-05Wells FargoMaintainsEqual-Weight$13.00 $12.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 53 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 1.9% above the 50-day MA ($11.77).
  • Price vs 200-day MA: Trading 1.7% above the 200-day MA ($11.80).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-0.04) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($10.40) and high ($12.91).

OCSL Price Chart

Loading chart for OCSL

Fundamentals

Revenue (TTM)$0M
EBITDA
Free cash flow$0M
Operating cash flow$0M
Book value / share$15.69
Net debt / EBITDA
WACC7.0%
Revenue growth-9.00%
Earnings growth

About Oaktree Specialty Lending Corpo

Oaktree Specialty Lending Corporation is a business development company. The fund specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity, and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering. The firm also seeks investment in media, advertising sectors, software, IT services, pharmaceuticals, biotechnology, real estate management and development, chemicals, machinery, and internet and direct marketing retail sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies. The firm invest in companies having enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.

More in Asset Management

Screen OCSL against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.